Anaxomics is an AI biotech company that uses cutting-edge technologies based on Systems Biology to overcome challenges in drug discovery and development, specializing in In Silico Clinical Trials. This innovative approach optimizes clinical trial efficiency and enhances our understanding of the mechanisms behind trial outcomes, thereby driving accelerated advancements in medical research

Our team consists of a high-qualified group of experts committed to pushing the boundaries of scientific knowledge and delivering innovative solutions to pharmaceutical and biotech companies, as well as researchers worldwide. At the core of our capabilities is our proprietary technology, Therapeutic Performance Mapping Systems (TPMS) technology, which has applications in both human and animal health. We offer our services through various engagement models, including fee-for-service and collaborative arrangements, ensuring that we cater to the unique needs of our clients and partners while consistently delivering high-quality results.

With a proven track record of successful projects and collaborations, we have built a reputation for excellence. Our flexible working arrangements and unwavering commitment to exceptional service guarantee success in every endeavor we undertake.